Qiagen NV | QIA - Operating Profit



Qiagen NV reported $135.97M in Operating Profit for its fiscal quarter ending in June of 2025.


Operating Profit Change Date
Alaunos Therapeutics USD -755000 395K Dec/2024
argenx SE USD 203.84M 64.9M Jun/2025
Avita Medical AUD -9957000 5.64M Dec/2024
Dianthus Therapeutics USD -34927000 3.01M Jun/2025
Ionis Pharmaceuticals USD 139.84M 285.84M Jun/2025
IQVIA Holdings USD 556M 64M Jun/2025
Moderna USD -907000000 143M Jun/2025
Organon & Co USD 326M 225M Jun/2025
Qiagen NV USD 135.97M 10.81M Jun/2025
Revvity USD 90.76M 18.53M Jun/2025
Tectonic Therapeutic USD -22330000 8.34M Jun/2025
Viatris USD 185.4M 3.21B Jun/2025
Xeris Pharmaceuticals USD 4.48M 2.8M Jun/2025